缅北强奸

Mathieu Maheu-Giroux, ScD

Sponsored Researcher, Department of Infectious Disease Epidemiology, Imperial College London (UK)

Modeling the population-level impact of HIV prevention in C么te D鈥橧voire

ALL ARE WELCOME

Abstract:

Despite a long-standing commitment to curb its epidemic, C么te d鈥橧voire has the highest recorded HIV prevalence in West Africa. Soon after the first AIDS case was reported in 1986 in Abidjan, a national response was mounted and a range of interventions have been scaled up during the 1990s and 2000s to address this health crisis. Most notably, these include: condom interventions, antiretroviral therapy (ART), and prevention of mother-to-child transmission (PMTCT) activities. Today, the UNAIDS aims to 鈥渆nd the AIDS epidemic as a major global health threat by 2030鈥� by considerably scaling up testing and treatment access (i.e., the UNAIDS 90-90-90 objective). In order to better understand the epidemic and estimate the population-level impact of different interventions, I developed a detailed age-stratified dynamical model of HIV transmission, parameterized it using local data, and fitted it to prevalence and programmatic data using a Bayesian framework. In this talk, I will (1) briefly discuss the role of models in impact evaluation, (2) assess the population-level impact of past HIV interventions (condoms, ART, and PMTCT) in C么te d鈥橧voire, and (3) estimate the effect on HIV transmission of accelerating the national response to reach UNAIDS 90-90-90 objective by 2020.

Bio:

Mathieu Maheu-Giroux is a Bisby Fellow at Imperial College London. He obtained a doctoral degree in Global Health & Population from the Harvard TH Chan School of Public Health (ScD鈥�15), Master鈥檚 degrees from 缅北强奸 in both Epidemiology (MSc鈥�09) and Ecology (MSc鈥�05), and an undergraduate degree in Biological Sciences from the Universit茅 de Montr茅al (BSc鈥�03). Dr. Maheu-Giroux鈥檚 work spans the areas of population health, epidemiology, and infectious diseases. Over the last years, he has focused primarily on impact evaluations of public health interventions, measurements and disease burden assessments, and behavioral interventions to control infectious diseases.

听